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Abstract
1a,25-dihydroxyvitamin D3 [1a,25(OH)2D3] is crucial for normal skeletal development and bone homeostasis. Protein
disulfide isomerase family A, member 3 (PDIA3) mediates 1a,25(OH)2D3 initiated-rapid membrane signaling in several cell
types. To understand its role in regulating skeletal development, we generated Pdia3-deficient mice and examined the
physiologic consequence of Pdia3-disruption in embryos and Pdia3+/2 heterozygotes at different ages. No mice
homozygous for the Pdia3-deletion were found at birth nor were there embryos after E12.5, indicating that targeted
disruption of the Pdia3 gene resulted in early embryonic lethality. Pdia3-deficiency also resulted in skeletal manifestations as
revealed by mCT analysis of the tibias. In comparison to wild type mice, Pdia3 heterozygous mice displayed expanded
growth plates associated with decreased tether formation. Histomorphometry also showed that the hypertrophic zone in
Pdia3+/2 mice was more cellular than seen in wild type growth plates. Metaphyseal trabecular bone in Pdia3+/2 mice
exhibited an age-dependent phenotype with lower BV/TV and trabecular numbers, which was most pronounced at 15
weeks of age. Bone marrow cells from Pdia3+/2 mice exhibited impaired osteoblastic differentiation, based on reduced
expression of osteoblast markers and mineral deposition compared to cells from wild type animals. Collectively, our findings
provide in vivo evidence that PDIA3 is essential for normal skeletal development. The fact that the Pdia3+/2 heterozygous
mice share a similar growth plate and bone phenotype to nVdr knockout mice, suggests that PDIA3-mediated rapid
membrane signaling might be an alternative mechanism responsible for 1a,25(OH)2D3’s actions in regulating skeletal
development.
Citation: Wang Y, Nizkorodov A, Riemenschneider K, Lee CSD, Olivares-Navarrete R, et al. (2014) Impaired Bone Formation in Pdia3 Deficient Mice. PLoS
ONE 9(11): e112708. doi:10.1371/journal.pone.0112708
Editor: Pierre J. Marie, Inserm U606 and University Paris Diderot, France
Received June 25, 2014; Accepted October 14, 2014; Published November 18, 2014
Copyright:  2014 Wang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. The authors confirm that all data underlying
the findings are fully available without restriction. All relevant data are within the Supporting Information files. The corresponding author may be contacted for
any additional information.
Funding: This study was funded by the Price Gilbert, Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* Email: bboyan@vcu.edu
Introduction
The vitamin D metabolite 1a,25-dihydroxyvitamin D3
[1a,25(OH)2D3] is an essential regulator of skeletal development
and homeostasis [1]. At the cellular level, it directly regulates
proliferation and differentiation of growth plate chondrocytes and
osteoblasts [2,3]. 1a,25(OH)2D3 exerts its biological effects
through two types of receptors: the traditional nuclear steroid
hormone vitamin D receptor (nVDR) and a membrane-associated
receptor, protein disulfide isomerase A3 (PDIA3), also referred to
as 1a,25(OH)2D3-membrane associated rapid response steroid
binding protein (1,25-MARRS), GRP58, ERp60, ERp58 and
ERp57 [4,5].
PDIA3 is a multiple function protein of the protein disulfide
isomerase family [6]. It is well known as a chaperonin, which can
assist glycoprotein folding and major histocompatibility complex I
loading [7]. It regulates endoplasmic reticulum stress and controls
cell survival [8]. It has also been shown to mediate 1a,25(OH)2D3
initiated rapid membrane responses in a variety of cell types.
Nemere et al. have demonstrated that PDIA3 directly contributes
to 1a,25(OH)2D3 induced calcium uptake by intestinal cells in
chicks and rats, which is important for mineral ion homeostasis
and bone mineral mass accumulation [9].
We have shown that PDIA3 is required for 1a,25(OH)2D3
activated protein kinase C-a (PKCa) signaling in both growth
plate chondrocytes and osteoblasts [2,3]. Upon binding to PDIA3
in caveolae on the membrane, 1a,25(OH)2D3 activates phospho-
lipase A2 (PLA2) and PLC, leading to downstream activation of
PKC [10–12] and extracellular regulated kinase (ERK) mitogen
activated protein kinases 1 and 2 (ERK1/2) [2,12,13]. In addition
to its non-genomic effects, PDIA3-dependent 1a,25(OH)2D3 rapid
membrane signaling also leads to genomic regulation of several
osteoblast markers and bone matrix mineralization in osteoblast
cultures [12,13]. These in vitro data suggest that the PDIA3-
mediated rapid membrane signaling pathway may play an
important role in 1a,25(OH)2D3 regulation of skeletal develop-
ment in vivo.
Cell culture studies support this. Growth plate chondrocytes
from nVdr knockout mice continue to exhibit increased PLA2,
PLC and PKC activity in response to 1a,25(OH)2D3 [14]. The
mechanism by which 1a,25(OH)2D3 elicits its actions in growth
plate chondrocytes involves direct interaction with caveolin-1
(CAV-1) in caveolae microdomains [15]. Interestingly, growth
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plate chondrocytes from Cav-1 knockout mice fail to respond to
1a,25(OH)2D3 with an increase in PKC [16]. Similarly, chondro-
cytes lacking intact caveolae also lack this rapid response to the
vitamin D metabolite. Moreover, Cav-12/2 knockout mice
exhibit a growth plate phenotype characterized by few hypertro-
phic chondrocytes compared to their Cav-1+/+ littermates [15].
The skeletal actions of 1a,25(OH)2D3 have been studied in
animal models and clinically. Vitamin D deficiency in animals and
children results in rickets, characterized by inadequate calcifica-
tion of the growth plate and adjacent metaphyseal bone [1,17].
Several nVdr knockout mice models have been created to study
the mechanisms involved in the development of the skeletal
phenotype of hereditary vitamin D resistant rickets, a human
disease associated with nVdr mutations [18–20]. These mice
exhibit a rachitic growth plate phenotype after weaning, support-
ing the hypothesis that a functional VDR is required for bone
development. Later studies showed that the rickets could be healed
by a calcium-rich rescue diet, suggesting that the rachitic changes
are a direct consequence of impaired endocrine function of
1a,25(OH)2D3 on mineral homeostasis, rather than impaired
VDR-dependent genomic actions on bone [21].
Recent studies examining effects of the rescue diet on the
morphology of the growth plate in nVdr2/2 mice showed that
although the rescue diet restored mineral deposition, it did not
restore formation of mineralized tethers to normal levels [22].
Tethers are mineralized regions in the growth plate that link the
epiphysis to the metaphysis, providing biomechanical stability
during long bone growth. They are distributed in a distinctive
pattern inside the circumference of normal growth plates as well as
within the central region. nVdr2/2 mice lack the circumferential
tethers whether they are fed the rescue diet or not [22], indicating
that their formation is VDR-dependent and is not secondary to
1a,25(OH)2D3’s actions on mineral ion homeostasis. Whether they
are PDIA3-dependent or not is not known.
Although these in vitro and in vivo data collectively suggest an
important role for PDIA3-mediated 1a,25(OH)2D3 rapid mem-
brane signaling in skeletal development, its involvement in
endochondral bone formation in vivo remains unknown. Attempts
to generate a Pdia3-null mouse have met with frustration, as
global ablation of the protein has resulted in embryonic lethality
[7,23]. Accordingly, mice that exhibited specific knockout in B-
cells were established to assess the role of PDIA3 in immune
function [7] and mice with specific knockout in intestinal epithelial
cells were established to assess the role of PDIA3 in mineral ion
transport [23]. In the present study, we opted to retain the global
knockout approach and to examine heterozygous mice in order to
gain a better understanding of how PDIA3 contributes to post-fetal
musculoskeletal development, which involves multiple tissues and
both systemic and biomechanical regulatory stimuli. Our results
show that Pdia3+/2 mice exhibit a mild skeletal phenotype
characterized by enlarged growth plates, reduced tether and
trabecular bone formation, and impaired osteogenic potential of
calvarial osteoblasts in vitro.
Materials and Methods
Ethics statement
All animal work was conducted under the approval of the
Georgia Institute of Technology IACUC.
Generation of Pdia3 knockout mice
A mouse embryonic stem cell (ESC) line (RST613, strain 129/
OlaHsd) (BayGenomics, USA) with an insertional mutation in
intron 1 of the Pdia3 gene was created using a gene-trapping
vector (Fig. 1A). The gene-trapped locus was predicted to yield a
fusion transcript containing exon 1 of the Pdia3 gene and a
reporter gene, bgeo encoding a fusion protein of b-galactosidase
and neomycin phosphotransferase II. The formation of non-
functional fusion protein was verified by examining
1a,25(OH)2D3-induced PKC activation. Wild-type E14TG2a.4
ESCs and RST613 single cell suspensions formed embryoid bodies
(EBs) by forced aggregation into AggreWell 400 inserts (Stem Cell
Technologies, Vancouver, CA) [24]. After 24 hours of culture in
the wells, aggregates were transferred into Petri dishes containing
10 ml of serum-free N2B27 media, which consisted of DMEM/
F12 (50/50) medium (Gibco, Grand Island, NY) supplemented
with N2 (Gibco), 25 mg/L bovine serum albumin (BSA), 100 U/
mL penicillin, 100 mg/mL streptomycin, and 0.25 mg/mL am-
photericin (Mediatech), 2 mM l-glutamine (Mediatech), all com-
bined 1:1 with Neurobasal medium (Gibco) supplemented with
B27 (Gibco) [25]. Aggregates were maintained on a rotary orbital
shaker at 40 rpm. Mesoderm induction was attained by additional
supplementation with 10 ng/mL BMP-4 (R&D Systems, Minne-
apolis, MN) during days 5–14 of culture. On day 14, EBs were
treated with vehicle (0.01% ethanol) or 1028 M 1a,25(OH)2D3 for
9 minutes. EBs were then lysed in RIPA buffer, and PKC activity
was measured and normalized to total protein content as described
previously [26].
The ESCs were injected into C57BL/6 blastocysts to create
chimeric mice, which were bred with C57BL/6 mice to generate
heterozygous Pdia3+/2 deficient mice. The Pdia3+/2 offspring
were then intercrossed. Mice were genotyped by PCR amplifica-
tion of tail DNA using prime pairs of a–b and a–c (Fig. 1A).
Sequences of the primer sets used for PCR are listed in Table S1.
The mice were weaned at 21 days of age, housed in a barrier
facility with a 12-h light-dark cycle, and maintained on standard
chow.
Examination of mice embryos
To obtain embryos from different stages, Pdia3+/2 heterozy-
gotes were intercrossed to produce timed pregnancies. At 1 p.m.,
we checked the vaginal plug and considered it as E0.5. Embryos
were isolated at different days of the pregnancy and stained with
arcridine orange (Sigma, USA) in PBS for 30 min at 37uC. After
extensive washes with PBS, the embryos were examined by
stereoconfocal microscopy. For detection of transgenic b-galacto-
sidase activity, the embryos were subjected to X-gal (Sigma, USA)
staining according to the manufacturer’s protocol. After examin-
ing the embryos microscopically, RNA, DNA and protein were
extracted from them using Trizol according to the manufacturer’s
instruction (Invitrogen, USA). DNA was subjected to genotyping
using primers described above, RNA was reverse transcribed into
cDNA and amplified using primers against Pdia3, ribosomal
protein s18 (S18) and neomycion (Neo). Sequences of the primer
sets used for PCR are listed in Table S1.
Proteins were solubilized in 2% diethylamine after TRIzol
extraction and subjected to 4–20% SDS/PAGE [27]. Blots were
incubated with antibodies against PDIA3 (Alpha Diagnostic
International, San Antonio, Texas, USA) or glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) (Millipore, Billerica, MA)
and imaged with VersaDoc imaging system (Bio-Rad, USA) as
described previously [12].
Gross examination of adult mice
The wild type and heterozygous mice at 5, 10, 15 and 30-weeks-
old were euthanized with CO2 inhalation following the IACUC
protocol. The body length was measured as the distance between
the nose and the end of the tail using a conventional ruler and the
Pdia3 and Bone
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bodies were weighed. Multiple organs including liver, kidney, and
heart were carefully dissected and weighed. The tibias on both
sides were dissected, the surrounding skin and muscle were
removed and the length of the tibias was measured using a caliper.
Expression of Pdia3 in the mice was measured in liver tissue to
verify that the heterozygotes had reduced levels of this mRNA.
mCT imaging and analysis
High-resolution mCT images of the left tibia of 5, 10, 15 and 30-
week-old Pdia3+/+ and Pdia3+/2 mice (n= 6) were obtained using
a Scanco VivaCT40 (Scanco Medical, Basserdorf, Switzerland)
with a voxel resolution of 12 mm. Specific regions of analysis
included the proximal tibial epiphysis, metaphysis, mid-diaphysis
and distal growth plate. Standard Scanco software was used to
determine microarchitecture morphology [16]. The growth plate
was isolated with user-guided contours and evaluated at a
threshold corresponding to 250 mg hydroxyapatite/cm3. Param-
eters derived at the tibial epiphysis and metaphysis included tissue
volume (mm3), bone volume (mm3), bone volume/tissue volume
(BV/TV %), trabecular number (#/mm), thickness (mm), and
spacing (mm). At the cortical tibia mid-diaphysis, mean cortical
area (mm2) and cortical thickness were determined through the
scanned volume of bone.
Tethers are bony structures in the growth plate linking the
epiphysis and metaphysis and are present in mice, rats, dogs, pigs,
and humans [22,28]. They have been linked to changing growth
plate morphology and fusion, and to providing tissue stability. Our
previous study extensively characterized the tether structure in
mouse growth plates and demonstrated its correlation with
functional nVdr [22,28]. Therefore, in this study, we adopted this
parameter to characterize Pdia3 heterozygous growth plates in
addition to other conventional measurements including growth
plate cartilage volume and properties of the hypertrophic zone. To
qualitatively assess tissue morphology and tether distribution, 3D
reconstructions of the growth plate were used to create 3D color
images to visualize growth plate morphology and 3D tether maps
to visualize formation within the growth center and along the
surface [28]. Parameters derived in growth plate including growth
plate volume (mm3) and tether volume/growth center volume.
Histology and histomorphometric analysis
For histology and histomorphometric analysis, the left tibiae
were fixed overnight in 4% paraformaldehyde. After rinsing in
PBS, the samples were subjected to decalcification by incubating
with cal-EX solution (Fisher Scientific Inc., USA) for 2 weeks.
Decalcified samples were then embedded in paraffin and sectioned
at 5-mm thickness. After deparaffinization, the sections were then
subjected to trichrome staining. Images were captured using a
Nikon Eclipse E100 microscope (Nikon Instruments Inc., Melville,
NY). The thickness of the proximal tibial growth plate and the
number of hypertrophic cells were then measured using Image Pro
software.
Figure 1. Generation of Pdia3 knockout mouse. A schematic representation of ablation of Pdia3 gene using gene trap vector inserted into the
intron 1 of mouse Pdia3 gene. The exons are numbered and indicated by solid blue boxes. Primers used for genotyping are indicated as a, b and c (A).
PKC activity of 1,25(OH)2D3 treated wild type and RST613 cells (B). *P,0.05 vs. vehicle treatment,
#P,0.05 vs. wild type. The samples collected from
E10.5 embryos were verified using genotyping (C), RT-PCR (D), western blot (E), and X-gal staining (F).
doi:10.1371/journal.pone.0112708.g001
Pdia3 and Bone
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In vitro osteogenic differentiation of bone marrow
progenitor cells isolated from wild type and
heterozygous mice
Phenotypic changes were evident in the tibias at 15 weeks of age
(see Results below), suggesting that changes at the cellular level
had occurred before that time. Accordingly, bone marrow stromal
cells (BMSCs) were isolated from 10-week-old wild type and
heterozygous mice tibiae as described previously [16]. Briefly,
tibias from Pdia3+/+ and Pdia3+/2 mice (n = 6 per group) were
flushed using a 21-gauge needle attached to a 10 mL syringe filled
with DMEM (GIBCO BRL, Gaithersburg, MD). Cells were
filtered through a cell strainer with 70-micron nylon mesh (BD
Bioscience, Bedford, MA) and then one million cells were plated in
each well of a 12-well plate and cultured in mesenchymal stem cell
growth media (a-MEM containing 10% FBS) at 37uC with 5%
humidified CO2. The media were changed after 24 hours to
remove non-attached cells and replaced with osteogenic medium
(a-MEM containing 10% FBS, 0.2 mM dexamethasone, 10 mM
b-glycerol phosphate and 50 mg/mL ascorbic acid). Media were
replaced every 2 days for up to 28 days of culture. For
measurement of osteoblast gene expression, cultures were
harvested at day 14 and day 28. RNA was extracted using
TRIzol (Invitrogen) and reverse-transcribed into cDNA using the
Omniscript RT kit (Qiagen, Valencia, CA) according to the
manufacturer’s directions. Real-time PCR was performed using
SYBR Green SuperMix 170–8882 (Bio-Rad) for collagen type I
(Col1), alkaline phosphatase (Alp), Runt-related transcription
factor 2 (RunX2), bone sialoprotein (Bsp), osteopontin (Opn),
and osteoprotegerin (Opg) and normalized to the level of
housekeeping gene ribosomal protein s 18 (S18). The real-time
PCR primers are listed in Table S2. Alkaline phosphatase activity
was measured at day 28 and normalized to protein content [12].
The level of osteocalcin in the media at day 28 was measured using
a mouse osteocalcin ELISA kit (Biomedical Technologies, Inc.)
according to manufacturer’s protocol and normalized to DNA
content. To assess mineralization, the 28-day cultures were fixed
in 10% formalin; alizarin red and von Kossa staining were
performed, and the positive staining area was quantified using
ImageJ software [16].
Statistical analysis
All measurements were collected with N=6 independent
determinations per data point. The data were expressed as mean
6 standard error and were subjected to independent Student’s t
tests. All statistical analyses were carried out using GraphPad 5.0
(GraphPad Software, Inc., La Jolla, CA). P,0.05 were considered
as statistically significant.
Results
Generation of pdia3 deficient mice
The functional disruption of the Pdia3 gene was confirmed by
the loss of response to 1a,25(OH)2D3 induced rapid PKC
activation in Pdia32/2 RST613 ESCs. While 1a,25(OH)2D3
treatment of wild type ESCs for 9 min resulted in a 4.9 fold
increase in PKC activity compared to vehicle treatment (P,0.05),
no significant PKC activation was observed in Pdia32/2 RST613
ESCs (Fig. 1B). These RST613 ESCs were then used to generate
Pdia3 knockout mice.
Global disruption of the Pdia3 gene resulted in embryonic
lethality. To determine the time of embryonic lethality, embryos
were collected from heterozygous intercrosses at different days of
gestation. No Pdia32/2 embryos were found after embryonic day
12.5. At E10.5, 2 out of 25 embryos were detected as Pdia32/2 by
PCR analysis (Fig. 1C). The absence of Pdia3 mRNA (Fig. 1D)
and protein (Fig. 1E), and the presence of b-galactosidase activity
(Fig. 1F) were confirmed by RT-PCR, western blot, and X-gal
staining, respectively.
Reabsorption of dead embryos in utero was observed (Fig. 2A).
Further stereo imaging analysis of E10.5 embryos showed that the
Pdia3+/+ (Fig. 2C, F) and pdia3+/2 embryos (Fig. 2D, G) were
similar in size and morphology, while the two Pdia32/2 embryos
at best were 2/3 of the Pdia3+/+ embryo size and displayed
hemorrhage around heart region (Fig. 2B) or had an open neural
tube (Fig. 2E, H).
Heterozygous mice were fertile, exhibited a normal life span
and did not show prominent pathological alterations. Genotype
analysis of 500 offspring from Pdia3+/2 intercrosses revealed 33%
were Pdia3+/+ wild type, 67% were Pdia3+/2 heterozygotes, and
none were Pdia32/2 homozygous. Gross anatomy analysis
(Fig. 3) showed that Pdia3+/2 mice had short body lengths (week
10, 15 and 30) but long tibias (week 15), and larger heart/body
ratios (week 15 and 30) in comparison to wild type mice. No
significant differences in body weight, body weight/body length,
and kidney/body ratio were observed.
Expression of 1,25(OH)2D3 receptors in pdia3+/2 mice
during the course of development
Real-time PCR analysis of liver tissue (Fig. 4) showed that the
expression of Pdia3 in heterozygous mice was 30–50% lower than
that of wild type mice through week 15 but by week 30, differences
in Pdia3 expression between wild type mice and heterozygous
mice were no longer evident. In contrast, nVdr expression in the
liver was similar between wild type and heterozygous mice at all
observation time points. nVdr expression increased at week 10
then decreased to the basal level (P,0.05) in both groups of mice.
Growth plate abnormality in pdia3+/2 mice
The growth plates of 10-week-old wild type mice contained a
number of tethers that displayed as bony bridge structures crossing
the growth plate and connecting the epiphysis and metaphysis in
2D mCT images (Fig. 5A) or hole-like structures in 3D
reconstruction images (Fig. 5B). However, these structures were
barely observed in the growth plates of heterozygous mice
(Fig. 5C, D). Quantitative analysis showed an age-dependent
increase in tether volume in both types of animals but it was
significantly lower in Pdia3+/2 mice in comparison to wild type
mice at week 5, 10 and 15 (Fig. 5F). In contrast, the cartilage
volume of growth plates was significantly higher in Pdia3+/2 mice
compared to wild type animals at both week 10 and 15 (Fig. 5E).
Histomorphometric analysis of histological sections also confirmed
that the growth plates of 10-week-old heterozygotes were about
20% thicker and hypertrophic zones contained 12% more cells
than those of wild type mice (Fig. 5G–L). Taken together, these
results consistently and collectively suggested a decrease of
mineralization of growth plate in Pdia3+/2 mice.
Bone phenotype in pdia3+/2 mice
An age-dependent bone phenotype was observed in tibias of
Pdia3+/2 mice by mCT and morphometric analysis (Tables 1 and
2). At week 5, no significant difference in trabecular bone was
found between wild type and heterozygous mice but at week 10,
Pdia3+/2 mice had a significantly lower number of trabeculae
within the epiphysis and BV/TV within the metaphysis in
comparison to wild type mice. At week 15, Pdia3+/2 mice
displayed significantly lower BV/TV and smaller trabecular
thickness, but larger trabecular space within both the epiphysis
Pdia3 and Bone
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and metaphysis compared to wild type. At week 30, no significant
difference was observed within the epiphysis. In contrast, the
Pdia3+/2 mice exhibited significantly higher BV/TV within the
metaphysis in comparison to wild type. Notably, no significant
difference in cortical bone was found at all ages (data not shown).
Impaired osteoblast differentiation potential of BMSCs
isolated from pdia3+/2 mice
Osteoblast differentiation of BMSCs was affected by Pdia3
deficiency. Although the expression of col1 and runx2 was similar
between the two types of cultures (P.0.05), the expression of
several osteoblast markers including alp, bsp, opn and opg was
significantly lower in Pdia3+/2 cultures in comparison to wild type
cultures at day 14 or day 28 (Fig. 6 A–F). In addition,
heterozygous cells also displayed significantly lower alkaline
phosphatase activity and produced less amounts of osteocalcin
than wild type cells (Fig. 6 G, H). By the end of 28 days of
osteogenic differentiation, the deposition of mineralized extracel-
lular matrix was less in heterozygous cultures than in wild type
cultures as indicated by smaller positive staining area of Alizarin
red and von Kossa (Fig. 6I).
Discussion
Due to embryonic lethality of global knockout of Pdia3, we
developed mice with null mutation in one allele of the gene in
order to study its role in skeletal development in post-fetal mice.
Comparison of wild type and heterozygote mice showed that
Pdia3 deficiency results in mild skeletal manifestations at both
growth plate and trabecular bone levels. The expansion of the
growth plate was associated with an increased hypertrophic zone
but decreased tether formation, which might contribute to the
reduced trabecular bone volume [15,28]. The impaired bone
formation can also be attributed to reduced osteogenic potential of
bone marrow cells in Pdia3+/2 mice as evidenced by their lower
mineralization capacity and reduced expression levels of osteoblast
markers when cultured in osteogenic media. Changes in bone
quantity may also be caused by altered bone resorption [16],
which was not investigated in this study.
The skeletal manifestations in Pdia3+/2 mice varied with post-
natal age and on the skeletal region. Lower numbers of growth
plate tethers in Pdia3+/2 mice were first detected at week 5. The
reduced number of tethers did not change with time, but growth
plate volume was larger, the number of hypertrophic cells was
greater and the number of trabeculae was reduced at week 10 in
Figure 2. Disruption of pdia3 gene resulted in malformation during embryogenesis. The partially absorbed embryos were observed at
E12.5 (A). E10.5 embryos were dissected and observed under stereomicroscopy (B, F–H) and confocal microscopy after acridine orange staining (C–E).
The wild type embryos (C, F) and heterozygous embryos (D, G) were similar in size and larger than homozygous embryos. One homozygous embryo
displayed hemorrhage around the heart area (B) and another one showed open neural tube (E, H). Scale bar = 1000 mm.
doi:10.1371/journal.pone.0112708.g002
Pdia3 and Bone
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the Pdia3+/2 mice. The differences in bone parameters between
wild type mice and heterozygotes were most pronounced at week
15 in both epiphysis and metaphysis. To our surprise, while no
significant differences were found in the growth plate and
epiphyseal bone at week 30, Pdia3+/2 mice displayed a higher
metaphyseal bone volume in comparison to wild type mice. This
observation was consistent with our previous study on the femoral
metaphysis of 15-week-old Pdia3+/2 mice, which showed
significant increases in trabecular and cortical bone volume [26].
The mechanisms underlying the age- and location-dependent
skeletal phenotypes of Pdia3+/2 mice are still not clear. However,
recent studies provide some clues that may contribute to the
observations reported here. First, Pdia3 and nVDR might serve as
a dominant 1a,25(OH)2D3 signaling mediator at different
development stages. Others have shown that in chickens,
1a,25(OH)2D3 elicits rapid stimulation of phosphate and calcium
transport in paralle with PKC activation in young birds but not
adult birds, due to gradual decrease in the binding affinity of
PDIA3 for 1,25(OH)2D3 [9]. In contrast, nVDR signaling remains
either unchanged or increases with age [9]. We reported that
PDIA3 is present in ESCs and mediates rapid 1a,25(OH)2D3-
dependent PKC activation prior to expression of nVdr [29].
Moreover, Pdia3 expression remains constant, whereas nVdr
expression increases over time. Similarly, in the present study,
Pdia3 expression was constant over time but there was an increase
in nVdr expression at week 10. The reduction in nVdr mRNA at
later time points suggests that PDIA3 signaling may play a more
dominant role in mediating the effects of 1a,25(OH)2D3 after week
10, which might explain why disruption of Pdia3 led to the
majority of bone phenotypes to occur in heterozygotes at week 15.
Further examination of PDIA3 protein production in the growth
plate and bone as well as functional disruption of 1a,25(OH)2D3
induced PKC activity in these Pdia3+/2 cells are essential to
elucidate the cellular mechanism of PDIA3’s action on skeletal
development.
Figure 3. Gross analyses of pdia3 wild type and heterozygous mice. The tissues from wild type and heterozygous mice were harvested at 5,
10, 15, and 30 weeks of age. The lengths of the body and tibia as well as the weight of the body and organs were then measured. N = 6, *P,0.05 vs.
wild type.
doi:10.1371/journal.pone.0112708.g003
Figure 4. Gene expression for two types of 1,25(OH)2D3
receptors in wild type and heterozygous mice. RNA was isolated
from the livers of wild type and heterozygous mice at 5, 10, 15, and 30-
weeks of age. The gene expression of Pdia3 (A) and nVdr (B) were
analyzed by real-time PCR and normalized to S18. N = 6, *P,0.05 vs.
wild type, #P,0.05 vs. week 5.
doi:10.1371/journal.pone.0112708.g004
Pdia3 and Bone
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The differential influence of disruption of Pdia3 on bones at
different regions might also be due to their unique skeletal
development process, geometrical and mechanical properties. The
epiphysis is formed during embryonic bone formation, whereas the
metaphysis is established post-fetally [16]. A progressive skeletal
phenotype was also observed in Cav-12/2 mice from epiphysis to
metaphysis [16]. Compared to the epiphysis, metaphyseal bone
also has much larger contact surface area with bone marrow,
Figure 5. mCT and histological analyses of growth plates from Pdia3 wild type and heterozygous mice. The left tibial growth plates were
harvested at 5, 10, 15 and 30 weeks of age. Representative 2D cross section of proximal left tibia (A, C) and 3D reconstruction images of the growth
plate (B, D) of 15-week of old wild type (A, B) and heterozygous mice (C, D). Tethers are indicated by a red box in 2D sections or an arrow in 3D
images. The morphometric analyses of mCT scans showing cartilage volume (E) and tether volume (F). Trichrome staining of a cross section of the
proximal left tibias of 10-week old wild type (G, I) and heterozygous mice (H, J). Histomorphometric analysis of growth plate thickness (K) and the
percentage of hypertrophic cells per growth plate section (L). White bar represents wild type mice and black bar represents heterozygotes. N= 6, *P,
0.05 vs. wild type.
doi:10.1371/journal.pone.0112708.g005
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which can regulate the bone formation through dynamic
remodeling [30]. Moreover, femurs and tibias have distinct
geometrical and mechanical properties [31,32], which can also
lead to their different phenotypic responses to PDIA3’s actions.
The skeletal phenotype of Pdia3+/2 mice was similar but not
identical to those of nVdr2/2 mice and/or Cav-12/2 mice.
Additionally, the extent of skeletal manifestations in Pdia3+/2
mice was not as pronounced as in the other two models, which
might be due to the partial deletion of Pdia3 rather than complete
ablation of nVdr or Cav-1, respectively. All of these animals have
expanded hypertrophic cartilage. Both nVdr2/2 and Pdia3+/2
mice have reduced tether formation indicating of failure of
calcification of cartilage [22,28], whereas a delayed closure of the
growth plate in Cav-12/2 mice is responsible for growth plate
expansion [15,16]. Both nVdr2/2 and Pdia3+/2 mice have
reduced trabecular bone volume whereas Cav-12/2 mice
exhibited increased bone formation [16,22]. In terms of osteogenic
potential, both osteoblasts from nVdr2/2 mice and bone marrow
cells from Cav-12/2 mice have demonstrated enhanced miner-
alized matrix formation and increased expression of osteoblast
markers [16,33]. In contrast, osteoprogenitor cells from bone
marrow of Pdia3+/2 mice showed decreased osteogenic potential.
While it is not surprising that these three mice models share
some features in their skeletal phenotypes in view that nVDR,
PDIA3, and CAV-1 are all involved in 1a,25(OH)2D3 signaling
pathways and the potential cross-talk among them, their unique
features indicate that these proteins might regulate skeletal
development through mechanisms other than as 1a,25(OH)2D3
effectors. It has been suggested that CAV-1 can recruit b-catenin
to caveolae and facilitate its subsequent nuclear translocation to
activate the canonical Wnt pathway and regulate osteoblast
differentiation and stem cell renewal [34,35]. Our in vitro studies
also show that silencing nVdr or Pdia3 in osteoblast-like MC3T3-
E1 cells leads to increased expression of BMP-2 and its inhibitor
Noggin [13], which indicates that these two proteins might be
Table 1. mCT analyses of tibia epiphyseal and trabecular bone phynotypes.
BV/TV
(%)
Trabeculae
(#/mm)
Trab. Th.
(mm)
Trab. Sp.
(mm)
5 weeks
Pdia3+/+ 58.362.4 14.460.8 0.06060.004 0.07160.003
Pdia3+/2 56.662.3 14.060.7 0.05960.003 0.07460.003
10 weeks
Pdia3+/+ 69.262.0 21.161.3 0.06060.005 0.05860.002
Pdia3+/2 68.562.8 17.561.2* 0.06260.007 0.05860.008
15 weeks
Pdia3+/+ 72.863.1 14.160.7 0.08360.004 0.07260.004
Pdia3+/2 59.362.2* 15.261.7 0.06860.004* 0.08460.003*
30 weeks
Pdia3+/+ 53.962.5 16.162.4 0.06260.006 0.07860.008
Pdia3+/2 57.862.1 15.661.4 0.06760.002 0.06660.006
N= 6, *P,0.05 vs. wild type.
doi:10.1371/journal.pone.0112708.t001
Table 2. mCT analyses of tibial metaphyseal and trabecular bone phynotypes.
BV/TV
(%)
Trabeculae
(#/mm)
Trab. Th.
(mm)
Trab. Sp.
(mm)
5 weeks
Pdia3+/+ 16.361.5 5.560.2 0.04660.001 0.18360.008
Pdia3+/2 14.460.8 5.360.3 0.04660.002 0.19060.008
10 weeks
Pdia3+/+ 14.461.8 6.360.7 0.05060.002 0.11560.031
Pdia3+/2 12.362.3 6.660.3* 0.05360.002 0.11560.008
15 weeks
Pdia3+/+ 27.461.3 5.860.2 0.05860.002 0.15260.005
Pdia3+/2 19.661.4* 5.660.2 0.05460.001* 0.17060.006*
30 weeks
Pdia3+/+ 6.960.5 4.260.1 0.04660.002 0.23960.008
Pdia3+/2 10.361.8 4.460.2 0.04960.002 0.22860.013
N= 6, *P,0.05 vs. wild type.
doi:10.1371/journal.pone.0112708.t002
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involved in osteoblast commitment thorough regulation of the
BMP-2 signaling pathway.
Of note, in addition to their skeletal phenotype, a greater heart
size of Pdia3+/2 mice was also observed after week 15, which
indicates the potential role of PDIA3 in cardiovascular develop-
ment. Interestingly, nVdr knockout and heterozygous mice also
exhibit larger hearts than wild type mice as well as cellular
hypertrophic changes in heart tissue at 12-months, which is
directly due to ablation of nVDR signaling [36,37]. Further studies
of the cardiovascular system in PDIA3-deficient mice will be
needed in order to reveal the mechanism involved.
In this study, no Pdia3 knockout mice were obtained after birth
confirming that global Pdia3 knockout is embryonically lethal, as
has been reported by others using different strategies for
generating the null mutation [7,38]. The Pdia32/2 embryo ratio
(8%, 2 of 25) at E10.5 was far below the predicted ratio of 25%
based on Mendelian distribution. The underrepresented
Pdia32/2 embryos at this stage indicated the reabsorption of
mal-developed Pdia3 null embryos in the uterus and suggested
that Pdia32/2 embryos died before E10.5. Although the two
identified null embryos were morphologically abnormal, the exact
onset and causes of embryonic lethality were not defined in this
study. Others have reported that Pdia3 ablation caused embryonic
lethality at E13.5 [38]. Different from our knockout strategy with
insertion of the gene trap vector in intron 1 of the Pdia3 alleles,
that study inserted the vector into intron 4 and obtained a longer
truncated PDIA3 protein containing partial functional groups
[38], which might explain the different embryonic lethality stages
observed between these two studies.
In conclusion, our results provide for the first time the in vivo
evidence that PDIA3 is critical for normal skeletal development in
post-natal mice. Partial disruption of Pdia3 leads to impaired bone
formation and genetic ablation of Pdia3 causes embryonic
lethality. Because the Pdia3-deficiency in this animal model is
not limited to cartilage or bone cells, it is not possible to define the
exact mechanism by which PDIA3 controls skeletal development.
In vitro studies examining the signaling pathways involved in
PDIA3-dependent effects of 1a,25(OH)2D3 in growth plate
chondrocytes and osteoblasts [39] support the hypothesis that
downstream actions of the vitamin D metabolite on cell function
are responsible for some of the observed phenotypic outcomes in
the Pdia3+/2 mice.
Development of conditional knockout mice with Pdia3 inacti-
vation in cartilage or bone is essential to elucidate the direct role of
PDIA3 in endochondral bone formation. Chondrogenesis pre-
cedes osteogenesis during embryonic development; thus, a bone-
Figure 6. Reduced osteogenic differentiation capacity of bone marrow stem cells isolated from pdia3+/2mice. The bone marrow stem
cells (BMSCs) were isolated from wild type and heterozygous mice and cultured in osteogenic media for 14 and 28 days. The expression of collagen
type I (Col1, A), alkaline phosphatase (Alp, B), Runt-related transcription factor 2 (Runx2, C), bone sialoprotein (Bsp, D), osteopontin (Opn, E) and
osteoprotegerin (Opg, F) were evaluated by real-time PCR and normalized to housekeeping gene ribosomal protein s 18 (S18). Alkaline phosphatase
activity (G) and the production of Osteocalcin (H) were measured in Day 28 cultures. Alizarin red and von Kossa staining were performed on Day 28
cultures to assess the mineralization and the positive staining areas were measured (I). White bar represents wild type culture and black bar
represents heterozygous culture. N= 6, *P,0.05 vs. wild type.
doi:10.1371/journal.pone.0112708.g006
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specific conditional knockout would not necessarily capture effects
of Pdia3 ablation on musculoskeletal outcomes. Moreover,
endocrine actions will not be excluded from these conditional
knockout systems. Mineral homeostasis is affected in chondrocyte-
specific nVdr-null mice [40], but it is not known whether PDIA3-
deficiency will also impact mineral metabolism. Therefore, levels
of Ca++ and phosphate in the blood as well as analysis of hormones
or other factors involved in bone or mineral homeostasis will be
vital to address the systemic effects of PDIA3 in controlling skeletal
development [41]. Additionally, in vitro studies using Pdia3
knockout ESCs will be a useful model at cellular level for
investigating the engagement of PDIA3-mediated 1,25(OH)2D3
signaling and its potential crosstalk with nVDR and CAV-1
signaling pathways in skeletal development. Finally, given the fact
that PDIA3 can regulate skeletal development, it might serve as a
target for musculoskeletal tissue engineering applications in the
future.
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